77872 Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Data Management and Sharing Plan ................... Grant Applicant ............. 73,117 1 2 146,234 

VCOC Certification ............................................... Grant Applicant ............. 6 1 5/60 1 

SBIR/STTR Funding Agreement Certification ...... Grant Applicant ............. 1,500 1 15/60 375 

PHS Fellowship—Electronic 

PHS Fellowship Supplemental Form (includes F 

reference letters).

Fellowship Grant Applicant.6,707 1 13 87,191 

Biosketch (Fellowship) .......................................... Fellowship Grant Applicant.6,707 1 2 13,414 

416–1 .................................................................... Fellowship Grant Applicant.29 1 10 290 

PHS 416–5 ........................................................... Fellowship Grant Applicant.6,707 1 5/60 559 

PHS 6031 ............................................................. Fellowship Grant Applicant.6,217 1 5/60 518 

NIH Other Transaction 

NIH Other Transaction Application Form ............. Other Transaction Applicant.239 1 11 2,629 

Total ............................................................... ....................................... 486,749 486,749 ........................ 2,175,670 

Dated: September 16, 2024. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2024–21801 Filed 9–23–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Cystic Fibrosis 

Research and Translation Centers. 

Date: October 31–November 1, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Ryan G. Morris, Ph.D., 

Scientific Review Officer, National Institute 

of Diabetes and Digestive and Kidney 

Diseases, National Institutes of Health, 6707 

Democracy Boulevard, Rm 7015, Bethesda, 

MD 20892–2542, 301–594–4721, 

ryan.morris@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: September 18, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–21739 Filed 9–23–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Post-Award 

Reporting Requirements Including 

Research Performance Progress 

Report Collection (Office of the 

Director) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Ms. Mikia P. Currie, Program 

Analyst, Office of Policy for Extramural 

Research Administration, 6705 

Rockledge Drive, Suite 350, Bethesda, 

Maryland 20892, or call a non-toll-free 

number 301–435–0941 or email your 

request, including your address to 

ProjectClearanceBranch@mail.nih.gov. 

Formal requests for additional plans and 


lotter on DSK11XQN23PROD with NOTICES1